Previous 10 |
home / stock / nxg:cc / nxg:cc news
TORONTO, ON / ACCESSWIRE / March 25, 2022 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the year ended December 31, 2021, highlighted by 12.01% revenue growth and EBITDA for the year of $3,503,957. Despite the many challenges created b...
News, Short Squeeze, Breakout and More Instantly...
TORONTO, ON / ACCESSWIRE / July 18, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the issuance of an aggregate of 195,312 common shares at a price of $0.32 in respect of the fourth quarterly equity payment under the Company's previously announced Consulting Agreement ...
TORONTO, ON / ACCESSWIRE / May 17, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2024, with revenue of $4,292,731, Net Income of $460,949 and EBITDA of $770,837. The Company achieved revenue of $4,292,731 in...
TORONTO, ON / ACCESSWIRE / May 16, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the results of its annual and special meeting (the "Meeting") of shareholders, which was held on Thursday, May 16, 2024. The Meeting was held, in part, to deliver the annual financial sta...